مطالب توسط

Ultraviolet Light in Human Health, Diseases and Environment

ABSTRACT

The use of ultraviolet (UV) light, for the treatment of skin conditions ,dates back to the early 1900s. It is well known that sunlight can be of therapeutic value, but it can also lead to deleterious effects such as burning and carcinogenesis. Extensive research has expanded our understanding of UV radiation and its effects in human systems and has led to the development of man-made UV sources that are more precise, safer, and more effective for the treatment of wide variety of dermatologic conditions.

INTRODUCTION

Ultraviolet (UV) light is an electromagnetic radiation varying in its wavelength from 100– 400 nm. At one side of this band is visible light which is longer than 400 nm starting with blue light and on the other is x-rays which is of shorter length than 100 nm. Two major sources of UV lights are: the sun and the man-made UV lamps. In earlier days the solar UV light, ranging from 180–400 nm, was divided in three basic types: UVA, 320–400 nm, UVB 290–320 nm and UVC 180–290 nm, but now is classifed into narrowband UVB of 311–313 nm, man-made Excimer laser of 380 nm, UVA2 of 320–340 nm and UVA 340–400 nm. Ultraviolet light has played a major role in biological research and according to (PubMed, November 2016) 82,617 research papers have been published involving UV light. UV light was discovered in 1801 by German Physicist, Johann Wilhelm Ritter. The discovery was based on his observation that there exist invisible rays of light beyond the violet end of the visible spectra, capable of darkening silver chloride-soaked paper more rapidly than the violet light itself, termed “Oxidizing rays”. Soon after its discovery, its name was changed to “chemical rays” but fnally these names were dropped in favor of ultraviolet rays. Then, in 1878 the effect of short-wavelength UV light on bacteria was discovered which was used in sterilization. The earliest record (PubMed, June 2016) of the role of UV light on a biological system is of 1903, when this light was used to treat Lupus in humans . Then, in 1922 the importance of UV light on living organisms was shown on Drosophila; a detailed monograph can be seen published in 1928, implicating the importance and application of UV light in therapeutics, . Although the exact type of UV light used is unknown, it is likely that short- wavelength UVC light was used in the experiments.

چکیده

استفاده از نور ماوراء بنفش (UV) برای درمان بیماری های پوستی به اوایل دهه 1900 باز می گردد. به خوبی شناخته شده است که نور خورشید می تواند از ارزش درمانی برخوردار باشد اما می تواند منجر به اثرات زیان آور مانند سوختن و سرطان زایی شود. تحقیقات گسترده ما درک ما از اشعه ماوراء بنفش و اثرات آن در سیستم های انسانی را گسترش داده است و منجر به توسعه منابع منفرد UV شده است که دقیق تر، ایمن تر و موثرتر برای درمان انواع مختلف بیماری های پوستی هستند.

مقدمه

نور UV (اشعه ماوراء بنفش) یک تابش الکترومغناطیسی است که در طول موج آن از 100 تا 400 نانومتر متغیر است. در یک طرف این باند نور قابل رویت است که طول آن بیش از 400 نانومتر است که از نور آبی شروع می شود و از سوی دیگر اشعه ایکس است که طول آن کمتر از 100 نانومتر است. دو منبع عمده از چراغ های UV عبارتند از: خورشید و اشعه ماوراء بنفش انسان. در روزهای اولیه، نور UV خورشیدی که از 180 تا 400 نانومتر بود، به سه نوع اساسی تقسیم شد: UVA، 320-400 نانومتر، UVB 290-320 نانومتر و UVC 180-290 نانومتر، اما اکنون به UVB باند باند 311 تقسیم شده است -313 نانومتر، لیزر اکسایمر ساخته شده از ماده 380 نانومتر، UVA2 320-340 نانومتر و UVA 340-400 نانومتر. نور نورفشانی نقش عمده ای در تحقیقات بیولوژیک ایفا کرده است و بر اساس (PubMed، نوامبر 2016) 82،617 مقاله پژوهشی منتشر شده است که شامل نور UV است. نور UV در سال 1801 توسط فیزیکدان آلمانی، یوهان ویلهلم ریتر کشف شد. این کشف بر اساس مشاهدۀ او بود که پرتوهای نامرئی نور بیش از انتهای بنفش طیف های قابل مشاهده وجود دارد که می تواند کاغذی را که به رنگ مایع کلرید نقره ای تیره شده است تیره تر کند، به همین ترتیب نور خود را بنام “اشعه اکسید کننده” نامید. به زودی پس از کشف آن، نام آن به “اشعه های شیمیایی” تغییر یافت اما این نام ها به نفع اشعه های ماورای بنفش افتاد. سپس، در سال 1878، اثر UV نور کوتاه مدت بر روی باکتری ها کشف شد که در عقیم سازی استفاده شد. اولین ضبط (PubMed، ژوئن 2016) از نقش نور UV بر سیستم بیولوژیکی، سال 1903 است، زمانی که این نور برای درمان لوپوس در انسان استفاده می شود. سپس، در سال 1922 اهمیت نور UV بر موجودات زنده بر روی Drosophila نشان داده شد؛ یک نقاشی دقیق را می توان در سال 1928 منتشر کرد، که اهمیت و کاربرد نور UV را در درمان دارد. اگر چه نوع دقیق نور UV استفاده شده ناشناخته است، احتمال دارد نور نور UVC کوتاه مدت در آزمایشات استفاده شود.

Year: 2016

Publisher: SPRINGER

By : Shamim I. Ahmad

File Information: English Language/ 367 Page / size: 6.42 MB

Only site members can download free of charge after registering and adding to the cart

Download tutorial

سال : 1395

ناشر : SPRINGER

کاری از : شامیم احمد

اطلاعات فایل : زبان انگلیسی / 367 صفحه / حجم : MB 6.42

فقط اعضای سایت پس از ثبت نام و اضافه کردن به سبد خرید می توانند دانلود رایگان کنند.خوشحال می شویم به ما پبیوندید

آموزش دانلود

The use of ultraviolet (UV) light, for the treatment of skin conditions ,dates back to the early 1900s. It is well known that sunlight can be of therapeutic value, but it can also lead to deleterious effects such as burning and carcinogenesis. Extensive research has expanded our understanding of UV radiation and its effects in human systems and has led to the development of man-made UV sources that are more precise, safer, and more effective for the treatment of wide variety of dermatologic conditions.

Tumor Organoids

Three-dimensional cell culture formats have been gaining popularity due to their ability to more closely mimic human physiology compared to conventional, two-dimensional culture. These 3D cultures exhibit in vivo-like behaviors, such as cell-cell adhesion, extracellular matrix secretion, and resilience against bacterial, chemical, and radiation insults. Various techniques for 3D organoid culture have been developed to recreate aspects of the lung microenvironment. This chapter examines the history and current applications of 3D lung tumor organoid culture, including Matrigel, hanging drop, magnetic levitation, rotating wall vessels, and non- adherent culture techniques. Each technique provides unique benefts for physiologic behavior, organoid access, and convenience. However, further work is required to advance the development of these systems for future biological discovery and high-throughput drug screening.

Tutorials in Endovascular Neurosurgery and Interventional Neuroradiology

From whence we come… What is the value of studying embryology when variant and anomalous vessels are so uncommon? Surely we always rely on a detailed analysis of each patient’s vascular anatomy to guide endovascular treatments. For me, anatomy is like a city street map. To be more precise, it is like the streets and roads of London, where I grew up. As a child I learnt to navigate those within walking distance of home and knew only main routes taken by car or bus to visit friends, shopping and other excursions. This familiarity of use fundamentally changed when I learnt to drive and was no longer a passive observer. Now, consider the role of chauffeur extended to showing visitors around my city. My priority changed, from learning shortcuts, good parking places and congestion avoidance (though all very useful to the city guide), to pointing out the sites and important historic places. We should learn the history of the routes we travel to deliver our therapy with the intimacy of the London cab driver and be prepared for the obscure address which few but they would know. In embryology we have a chance to marvel at the compressed evolution of foetal development. By learning about those processes, we are delighted when recognising throwbacks and anomalies, which, like historic sites, provide evidence of ‘from whence we come’.

Cardio-Nephrology

Human endothelial cells were first propagated in culture in the early 1970s . To date, there have been major subsequent advances in our understanding of endothelial cell (EC) biology based upon this critically important technology. However, it is still apparent that ECs tend to dedifferentiate and lose their specialized characteristics in culture. Endothelial cells (ECs) form the lining of all blood and lymphatic vessels within the vascular tree. In the last two decades, one of the major achievements in medicine has been defining the biology of vascular endothelium. The endothelium is not a simple, inert semipermeable structure, which merely served to line blood vessels. Strategically located between the wall of blood vessels and the blood stream, it forms an active organ with endocrine and paracrine functions. The human body contains approximately 1013 endothelial cells weighing approximately 1 kg, covering a surface area of 4000–7000 m2 equivalent to a football playground. The endothelial cell monolayer forming the inner lining of all blood vessels within the vascular tree, covering glycocalyx, and underlying basement membrane constitutes the endothelium. Due to the complex nature of the endothelium, studies on its function transcend all existing organ-specific disciplines (Fig. 1.1). The endothelium first functions as a physical barrier, defining the components of the vessel wall and the contents of the vessel lumen. Second, this barrier affords movement of small solutes in preference to large molecules, therefore it is involved in regulating cellular and nutrient trafficking. The endothelium also mediates vasoactivity, maintains blood fluidity, and contributes to the local balance between pro- and anti-inflammatory mediators as well as pro- and anticoagulant activity (Fig. 1.1).

Botulinum Toxin for Asians

Botulinum toxin type A (BoNT-A) is a neurotoxin produced by the gramnegative, rod-shaped bacterium Clostridium botulinum. It causes muscle paralysis through inhibition of acetylcholine release at the neuromuscular junction. Since the ingenious American ophthalmologist Dr. Alan Scott first used the BoNT-A to treat patients with strabismus, BoNT-A exploded in popularity and has since been used in treating a number of inappropriate excessive muscle contractions including blepharospasm and cervical dystonia. In the late 1980s, during a clinical study for treating blepharospasm with BoNT-A, a Canadian ophthalmologist, Jean Carruthers, observed that patients participating in the study wanted to continue to receive BoNT-A injection despite of improvement of blepharospasm because glabellar lines and periorbital lines disappeared along with blepharospasm. She mentioned this interesting observation to her husband, Alastair Carruthers, a dermatologist. This led to publish the world’s first article using BoNT-A for wrinkle treatment . Since then BoNT-A has become a byword for the treatment of wrinkles. Since approved to treat blepharospasm and strabismus by the US FDA in 1989, BoNT-A has continued to expand its indication for the treatment of inappropriate excessive muscle contractions including cervical dystonia (approved by the US FDA in 2000), focal upper limb spasticity (approved by the US FDA in 2010), detrusor overactivity (neurogenic bladder) (approved by the US FDA in 2011), juvenile cerebral palsy, stroke (for rehabilitation therapy), and anal fissure. The BoNT-A has also been proven highly effective in treating focal hyperhidrosis of the axillae (approved by the US FDA in 2004), palms, and soles, since it inhibits secretion of the eccrine sweat glands innervated by the sympathetic nervous system.

Bacterial Infections and the Kidney

APSGN remains a significant clinical entity in spite of declining incidence rate in the pediatric population in well- developed countries. In developed countries APSGN became very rare but may still appear in adults with comorbidities, primarily diabetes mellitus and morbid obesity. APSGN is still prevalent in many parts of the world. In the past, it was the most common and the most studied form of acute postinfectious glomerulonephritis. These extensive studies provided us with invaluable information about the pathogenesis of acute glomerulonephritis, not only APSGN, but other forms of glomerulonephritides as well. Acute glomerulonephritis has been known to follow certain infections a long time ago. Already, Hippocrates described the occurrence of back pain and gross hematuria leading to oliguria or anuria more than two millennia ago . About two centuries ago, Wells noted bloody urine in patients with scarlet fever and postscarlatinal anasarca . Later, Bright noted the association with scarlatina and described the finding of blood in the urine and swelling of the face in what were probably attacks of APSGN . Therefore, acute glomerulonephritis was named after Bright (Bright’s disease).

Practical Approach to Peripheral Arterial Chronic Total Occlusions

An estimated 8–12 million Americans are believed to suffer from peripheral arterial disease (PAD) according to the American Heart Association. The prevalence of PAD has been estimated at almost 10% in the general population and almost 20% in those older than 70 years. Patients with PAD present a unique challenge to the provider due to their typically older age, high rates of underdiagnosis due to asymptomatic state, and the higher prevalence of comorbid conditions. The prototypical risk factors for PAD are similar to that of coronary arterial disease and include tobacco use, hyperlipidemia, hypertension, and diabetes. The mainstay of PAD therapy is aggressive risk factor modifcation followed by pharmacologic therapy and exercise therapy as warranted.

The SAGES Manual Transitioning to Practice

After many years of medical school, the residency match process, general surgery residency training, research fellowships, and additional fellowship match processes and training programs, you are ready and excited to take care of surgical patients both in and out of the operating room. You are ambitious and idealistic, ready to emerge from all of those grueling years to finally be a “surgeon.” The training of a surgeon,
however, rarely focuses on life after residency. And this life after residency starts with your first job. Furthermore, there is startling data regarding dissatisfaction physicians in general often have with their first jobs. In fact, approximately 50% of physicians change jobs within their first 2 years, and the most common reason for this is a mismatch in expectations and practice culture . The goal of this section is to prepare the surgical trainee in his or her final years of training for the daunting task of navi gating the surgical job market in order to maximize the odds of finding a job that fits one’s expectations. Later chapters in this manual will cover both the process of choosing a job as well as salary and contract negotiations. In this chapter, however, the focus will be on the first step of the job hunt, finding a job.

Respiratory Outcomes in Preterm Infants

The archetypal lung disease in preterm infants and one of the more common complications of preterm birth is bronchopulmonary dysplasia (BPD), which may include both parenchymal and small airway components. Common clinical manifestations of BPD include hypoxia, hypercarbia, tachypnea, and asthma-like symptoms . “Classic” or “old” BPD was frst described in 1967 by Northway et al. , and was characterized by inflammation with airway injury and alveolar fbrosis. Over time, BPD has evolved (“new” BPD), particularly with use of newer ventilation strategies and exogenous surfactant, to a phenotype characterized by fewer and larger simplifed alveoli with dysnaptic growth of the pulmonary vascular bed . Although several defnitions of BPD or chronic lung disease of prematurity have been used since 1967 , currently the most widely agreed
upon defnition of BPD was developed at a NICHD workshop published in 2001 . At this workshop, the diagnosis and severity of BPD in premature infants were based on gestational age (<32 weeks or ≥32 weeks) and need for oxygen and/or respiratory support at specifed time points. This defnition was subsequently validated in 2005 . It should be recognized that this oxygen-based defnition could overestimate or underestimate the incidence of BPD as goal oxygen saturations remain controversial and can vary among clinical centers . Additionally, this oxygen-based defnition may overestimate the incidence of BPD in clinical sites at higher altitudes where the partial pressure of oxygen is decreased .